Phillips Edison & Company PECO Proceeds From Sale Of Notes Receivable

Proceeds From Sale Of Notes Receivable at other companies

Ingram MicroINGM

$10.18M-7.4%

Agilent TechnologiesA

$500K—

Primoris ServicesPRIM

$8M—

NNN REITNNN

$0-100%

Sabra HealthcareSBRA

$1.94M+72.2%

American Healthcare REITAHR

$0-100%

Other financials

Income statement

See full

Revenue$190.7M+7.0%

Net income$30.4M+15.5%

EPS (diluted)$0.24+14.3%

Balance sheet

See full

Cash & equivalents$3.1M-42.5%

Total debt$2.5B+9.3%

Total equity$2.3B-1.4%

Total assets$5.4B+3.7%

Cash flow

See full

Operating cash flow$55.6M-8.2%

CapEx$13.3M+37.7%

Free cash flow$42.3M-16.9%

Valuation

See full

Market cap$5.13B+3.0%

Profitability

See full

Net margin15.6%+5.1pp

FCF margin44.1%-1.8pp

Returns & leverage

See full

Return on equity5%+1.9pp

Debt / equity1.1×+0.1×

Where this comes from

Reported directly by Phillips Edison & Company in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfNotesReceivable.

The official record: Phillips Edison & Company’s 10-Q, filed April 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phillips Edison & Company's proceeds from sale of notes receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Phillips Edison & Company's proceeds from sale of notes receivable?: Phillips Edison & Company (PECO) reported proceeds from sale of notes receivable of $3.78M in Q1 2026.